You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

711 Results
The following information answers many of the questions primary care physicians commonly ask about the Screening Activity Report and the included...
Symptom Management
Symptom Management
Document
Jul 2024
Document
Jul 2024
Document
Jul 2024
Document
Jul 2024
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant
Funding:
New Drug Funding Program
    Pembrolizumab - (Neo)adjuvant Therapy for Resectable Non-Small Cell Lung Cancer
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
pembrolizumab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Sep 2025
Document
Sep 2024
Document
Sep 2024
Document
Oct 2024

Pages